Laura Mosca

Dr. Laura Mosca

Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, Via Luigi De Crecchio 7, 80138 Naples, Italy
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ACAlessia Maria Cossu
Alessia Maria Cossu
LMLaura Mosca
Laura Mosca
SZSilvia Zappavigna
Silvia Zappavigna
GMGabriella Misso
Gabriella Misso
MBMarco Bocchetti
Marco Bocchetti
Mariarosaria BoccellinoMariarosaria Boccellino
Mariarosaria Boccellino
Head and neck carcinoma (HNC) is a heterogeneous disease encompassing a variety of tumors according to the origin. Laryngeal cancer (LC) represents one of the most frequent tumors in the head and neck region. Despite clinical studies and advance in treatment, satisfactory curative strategy has not yet been reached. Therefore, there is an urgent need for the identification of specific molecular signatures that better predict the clinical outcomes and markers that serve as suitable therapeutic targets. Long non-coding RNAs (lncRNA) are reported as important regulators of gene expression and represent an innovative pharmacological application as molecular biomarkers in cancer. The purpose of this review is to discuss the most relevant epigenetic and histological prognostic biomarkers in HNC, with particular focus on LC. We summarize the emerging roles of long non-coding RNAs in HNC and LC development and their possible use in early diagnosis.

22 April 2020 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
RPRita Polito
Rita Polito
VMVincenzo Monda
Vincenzo Monda
ENErsilia Nigro
Ersilia Nigro
AMAntonietta Messina
Antonietta Messina
GMGirolamo Di Maio
Girolamo Di Maio
GMGiovanni Messina
Giovanni Messina
Exercise represents the most important integrative therapy in metabolic, immunologic and chronic diseases; it represents a valid strategy in the non-pharmacological intervention of lifestyle linked diseases. A large body of evidence indicates physical exercise as an effective measure against chronic non-communicable diseases. The worldwide general evidence for health benefits are both for all ages and skill levels. In a dysregulated lifestyle such as in the obesity, there is an imbalance in the production of different cytokines. In particular, we focused on Adiponectin, an adipokine producted by adipose tissue, and on Orexin-A, a neuropeptide synthesized in the lateral hypothalamus. The production of both Adiponectin and Orexin-A increases following regular and structured physical activity and both these hormones have similar actions. Indeed, they improve energy and glucose metabolism, and also modulate energy expenditure and thermogenesis. In addition, a relevant biological role of Adiponectin and Orexin A has been recently highlighted in the immune system, where they function as immune-suppressor factors. The strong connection between these two cytokines and healthy status is mediated by physical activity and candidates these hormones as potential biomarkers of the beneficial effects induced by physical activity. For these reasons, this review aims to underly the interconnections among Adiponectin, Orexin-A, physical activity and healthy status. Furthermore, it is analyzed the involvement of Adiponectin and Orexin-A in physical activity as physiological factors improving healthy status through physical exercise.

4 December 2018 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
CIConcetta Paola Ilisso
Concetta Paola Ilisso
DCDonatella Delle Cave
Donatella Delle Cave
LMLaura Mosca
Laura Mosca
MPMartina Pagano
Martina Pagano
ACAlessandra Coppola
Alessandra Coppola
MPMarina Porcelli
Marina Porcelli
To get insight into the molecular mechanisms underlying the anti-tumor activity of S-adenosyl-l-methionine (AdoMet), we analyzed AdoMet-induced modulation of microRNAs (miRNAs) expression profile in MCF-7 breast cell line and its correlation with cancer-related biological pathways. MiRNA expression profiling was performed using a TaqMan MiRNA Array, following 500 µM AdoMet-treatment. The results were confirmed by Quantitative real-time PCR analysis. MCF-7 were transfected with miR-34a, miR-34c and miR-486-5p, mimics and inhibitors in presence or not of 500 µM AdoMet for 72 h. Apoptosis and autophagy were analyzed by flow cytometry and the modulation of the main antiproliferative signaling pathways were evaluated by Western blotting. The potential mRNA targets for each miRNA were identified by the TargetScan miRNA target prediction software. Twenty-eight microRNAs resulted differentially expressed in AdoMet-treated MCF-7 cells compared to control cells. Among them, miRNA-34a and miRNA-34c were up-regulated while miRNA-486-5p was down-regulated. Moreover, we confirmed the ability of AdoMet to regulate these miRNAs in MDA-MB 231 breast cancer cell line. We demonstrate that, in MCF7 cells, the combination of either miR-34a or miR-34c mimic with AdoMet greatly potentiated the pro-apoptotic effect of AdoMet, by a caspase-dependent mechanism and activates p53 acetylation by inhibiting SIRT1 and HDAC1 expression. We also showed that miR-486-5p inhibitor induces autophagy and enhances AdoMet-induced autophagic process by increasing PTEN expression and by inhibiting AKT signaling. Our findings provide the first evidence that AdoMet can regulate miRNA expression in MCF-7 increasing our knowledge on the molecular basis of the antitumor effect of the sulfonium compound and suggest the use of AdoMet as an attractive miRNA-mediated chemopreventive and therapeutic strategy in breast cancer.

22 June 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
DCDonatella Delle Cave
Donatella Delle Cave
Vincenzo DesiderioVincenzo Desiderio
Vincenzo Desiderio
LMLaura Mosca
Laura Mosca
CIConcetta Paola Ilisso
Concetta Paola Ilisso
LMLuigi Mele
Luigi Mele
MPMarina Porcelli
Marina Porcelli

10 April 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
VGVincenzo Grassia
Vincenzo Grassia
AAngela Lombardi
Angela Lombardi
HKHiromichi Kawasaki
Hiromichi Kawasaki
CFCarmela Ferri
Carmela Ferri
LPLetizia Perillo
Letizia Perillo
Michele CaragliaMichele Caraglia
Michele Caraglia
Salivary microRNAs as new molecular markers in cleft lip and palate: a new frontier in molecular medicine Salivary microRNAs as new molecular markers in cleft lip and palate: a new frontier in molecular medicine

13 October 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LMLuigi Mele
Luigi Mele
VVVitale Del Vecchio
Vitale Del Vecchio
FMFrancesco Marampon
Francesco Marampon
TRTarik Regad
Tarik Regad
SWSarah Wagner
Sarah Wagner
ABAntonio Barbieri
Antonio Barbieri
The β2-Adrenergic receptor (β2-AR) is a G protein-coupled receptor (GPCR), involved in the development of many cancers, among which HNSCC. In this contest, β2-AR signaling interacts with different pathways, such as PI3K and MAPK, commonly activated by TK receptors. For this reason, TK blockade is one of the most adopted therapeutic strategies in HNSCC patients. In our study we investigated the effects of the β2-AR blocking in HNSCC cell lines, using the selective inhibitor ICI118,551 (ICI), in combination with the MAPK inhibitor U0126. We found that ICI leads to the blocking of p38 and NF-kB oncogenic pathways, strongly affecting also the ERK and PI3K pathways. Cotreatment with U0126 displays a synergic effect on cell viability and pathway alteration. Interestingly, we found that the β2-AR blockade affects Nrf2-Keap1 stability and its nuclear translocation leading to a drastic ROS increase and oxidative stress. Our results are confirmed by a TCGA dataset analysis, showing that NFE2L2 gene is commonly overexpressed in HNSC, and correlated with a lower survival rate. In our system, the PI3K pathway inhibition culminated in the blocking of pro-survival autophagy, a mechanism normally adopted by cancer cells to became less responsive to the therapies. The mTOR expression, commonly upregulated in HNSC, was reduced in patients with disease-recurrence. It is well known that mTOR has a strong autophagy inhibition effect, therefore its downregulation promoted pro-survival autophagy, with a related increase recurrence rate. Our findings highlight for the first time the key role of β2-AR and related pathway in HNSCC cell proliferation and drug resistance, proposing it as a valuable therapeutic molecular target.